Articles 30-day mortality after systemic anticancer treatment for breast and lung cancer in England: a population-based, observational study

Our findings show that several factors affect the risk of early mortality of breast and lung cancer patients in England and that some groups are at a substantially increased risk of 30-day mortality. The identification of hospitals with significantly higher 30-day mortality rates should promote review of clinical decision making in these hospitals. Furthermore, our results highlight the importance of collecting routine data beyond clinical trials to better understand the factors placing patients at higher risk of 30-day mortality, and ultimately improve clinical decision making.
Source: The Lancet Oncology - Category: Cancer & Oncology Authors: Tags: Articles Source Type: research

Related Links:

SUMMARY OBJECTIVE: CT perfusion (CTP) is an imaging technique that can be used to evaluate the changes in the microcirculation of tumor tissues. Our study aimed to investigate the role of CTP in predicting mediastinal lymph node metastasis. METHODS: Clinical data of 58 patients who received surgical resection of lung cancer and lymph node dissection in our hospital from June 2012 to December 2014 were collected. Patients were divided into a positive lymph node metastasis group and a negative lymph node metastasis group. Parameters of CTP, including peak enhancement intensity (PEI), perfusion value (PV), as well as blood vo...
Source: Revista da Associacao Medica Brasileira - Category: General Medicine Source Type: research
CONCLUSIONS We found that PVT1 promotes angiogenesis through targeting the miR-29c/VEGF signaling pathway in NSCLC. PMID: 31326971 [PubMed - in process]
Source: Medical Science Monitor - Category: Research Tags: Med Sci Monit Source Type: research
This study measure the efficiency and productivity of breast and lung cancer health care provision in Europe in order to inform related policy discussions. The included countries’ relative performance is measured against a best practice production frontier computed using distance functions where inputs are used to produce an output. The distance function is well suited to identify best practice in a complex production process such as cancer care with rapid change in technologies.Price data is not needed which is an advantage when evaluating the European health care sector where market prices often are non-existent. I...
Source: Journal of Cancer Policy - Category: Cancer & Oncology Source Type: research
Source: OncoTargets and Therapy - Category: Cancer & Oncology Tags: OncoTargets and Therapy Source Type: research
This article is licensed under aCreative Commons Attribution-NonCommercial 3.0 Unported Licence.Keum-Soo Song, Satish Balasaheb Nimse, Shrikant Dashrath Warkad, Ae-Chin Oh, Taisun Kim, Young Jun Hong Population-based screening of stage 0 –I lung cancer is crucial for saving lives. The CIC/CYFRA 21-1 ratio allows the detection of stage I lung cancer with 76.0% sensitivity and 87.5% specificity. To cite this article before page numbers are assigned, use the DOI form of citation above. The content of this RSS Feed (c) The Royal Society of Chemistry
Source: RSC - Chem. Commun. latest articles - Category: Chemistry Authors: Source Type: research
Condition:   Small Cell Lung Carcinoma Interventions:   Drug: Atezolizumab;   Drug: Carboplatin;   Drug: Etoposide Sponsor:   Hoffmann-La Roche Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Lung Cancer;   Non Small Cell Lung Cancer Interventions:   Drug: LMB-100;   Drug: pembrolizumab;   Diagnostic Test: Mesothelin Expression Sponsor:   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Small Cell Lung Carcinoma Interventions:   Drug: Atezolizumab;   Drug: Carboplatin;   Drug: Etoposide Sponsor:   Hoffmann-La Roche Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Lung Cancer;   Non Small Cell Lung Cancer Interventions:   Drug: LMB-100;   Drug: pembrolizumab;   Diagnostic Test: Mesothelin Expression Sponsor:   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Source: OncoTargets and Therapy - Category: Cancer & Oncology Tags: OncoTargets and Therapy Source Type: research
More News: Cancer | Cancer & Oncology | Clinical Trials | Hospitals | Lung Cancer | Study